Salvus Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
1,890
+5
| +0.3% | +$3.9K | 0.86% | 34 |
|
|
2025
Q1 | $1.56M | Buy |
1,885
+215
| +13% | +$178K | 0.98% | 33 |
|
|
2024
Q4 | $1.29M | Buy |
1,670
+281
| +20% | +$217K | 0.82% | 32 |
|
|
2024
Q3 | $1.23M | Buy |
1,389
+45
| +3% | +$39.9K | 0.76% | 35 |
|
|
2024
Q2 | $1.22M | Buy |
1,344
+7
| +0.5% | +$6.34K | 0.84% | 32 |
|
|
2024
Q1 | $1.04M | Buy |
1,337
+96
| +8% | +$74.7K | 0.71% | 38 |
|
|
2023
Q4 | $724K | Buy |
1,241
+25
| +2% | +$14.6K | 0.51% | 51 |
|
|
2023
Q3 | $653K | Buy |
1,216
+54
| +5% | +$29K | 0.52% | 54 |
|
|
2023
Q2 | $545K | Buy |
1,162
+12
| +1% | +$5.63K | 0.42% | 65 |
|
|
2023
Q1 | $395K | Sell |
1,150
-15
| -1% | -$5.15K | 0.32% | 82 |
|
|
2022
Q4 | $426K | Hold |
1,165
| – | – | 0.39% | 64 |
|
|
2022
Q3 | $377K | Buy |
1,165
+25
| +2% | +$8.09K | 0.36% | 73 |
|
|
2022
Q2 | $370K | Sell |
1,140
-4
| -0.3% | -$1.3K | 0.33% | 76 |
|
|
2022
Q1 | $328K | Buy |
1,144
+55
| +5% | +$15.8K | 0.25% | 84 |
|
|
2021
Q4 | $301K | Buy |
1,089
+186
| +21% | +$51.4K | 0.22% | 84 |
|
|
2021
Q3 | $209K | Hold |
903
| – | – | 0.17% | 99 |
|
|
2021
Q2 | $209K | Buy |
+903
| New | +$209K | 0.18% | 94 |
|